What is Neurava?
Neurava is pioneering a new generation of smart wearables designed to identify and alert users to critical health events, including seizures, cardiorespiratory dysfunctions, and the risk of Sudden Unexpected Death in Epilepsy (SUDEP). This innovative diagnostic platform, born from the expertise of its founders, aims to provide a vital safety net for millions globally affected by epilepsy and other serious conditions. The company's technology represents a significant advancement in remote patient monitoring and proactive health management.
How much funding has Neurava raised?
Neurava has raised a total of $3.9M across 2 funding rounds:
Angel/Seed
$2.3M
Private Equity
$1.6M
Angel/Seed (2024): $2.3M with participation from Elevate Ventures, First Leaf Capital, and Life Science Angels
Private Equity (2025): $1.6M, investors not publicly disclosed
Key Investors in Neurava
Elevate Ventures
Elevate Ventures is an investment firm focused on supporting innovation-driven companies across various sectors, particularly at the Pre-Seed, Seed, and Series A stages. They provide crucial funding and strategic guidance to entrepreneurs, emphasizing founders with strong drive and creativity.
First Leaf Capital
First Leaf Capital is an investment firm specializing in startup capital, small business loans, and micro-private-equity transactions. They support entrepreneurs with innovative products addressing significant problems, offering quick decisions and strategic assistance.
Life Science Angels
Life Science Angels is a prominent angel investment group dedicated to early-stage life science companies. They provide investment opportunities and support to entrepreneurs within the life sciences sector.
What's next for Neurava?
The substantial enterprise-level funding and recent strategic investment signal Neurava's readiness to scale its operations and accelerate the market penetration of its groundbreaking wearable technology. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and support broader clinical validation and regulatory approvals. Neurava is strategically positioned to become a leader in the MedTech space, offering a potentially life-saving solution for individuals at high risk of sudden health crises.
See full Neurava company page
